PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'INSERM, IAME, University of Paris, 75006, Paris, France.\', \'Medical and Infectious Diseases Intensive Care Unit, APHP, Bichat University Hospital, Paris, France.\', \'INSERM, IAME, University of Paris, 75006, Paris, France. niccolo.buetti@gmail.com.\', \'Infection Control Program and WHO Collaborating Centre on Patient Safety, Service PCI, University of Geneva Hospitals and Faculty of Medicine, Rue Gabrielle-Perret-Gentil 4, 1205, Geneva, Switzerland. niccolo.buetti@gmail.com.\', \'Virology Department, GH APHP.Nord, Bichat-Claude Bernard University Hospital, 75018, Paris, France.\', \'INSERM, UMR1148, Université de Paris, 75018, Paris, France.\', \'Virology Department, GH APHP.Nord, Université de Paris, IAME INSERM UMR1137, Bichat-Claude Bernard University Hospital, 75018, Paris, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s13054-021-03843-8
?:hasPublicationType
?:journal
  • Critical care (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 34872611
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • HSV-1 reactivation is associated with an increased risk of mortality and pneumonia in critically ill COVID-19 patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all